Neurent Medical Press Releases

If you are a HealthCare Professional: Contact Customer Service to Place an Order

Neurent Medical Press ReleasesAd Min2023-03-21T18:40:33+00:00

SOME OF OUR

Recent News

Stay up to date with the latest news from Neurent Medical

New Data show NEUROMARK^® Chronic Rhinitis Treatment Offers Significant Symptom Improvements

21st March 2023

Significant Symptom Improvements

Neurent Medical Announces Limited Market Release of NEUROMARK^® System to Treat Chronic Rhinitis

3rd February 2023

Press release about Limited Release

Neurent Medical Receives FDA Clearance for NEUROMARK^™, a Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis

18th November 2021

Press release about FDA Clearance

Neurent Medical Expands Leadership Team to Support Advancement of In-Office Chronic Rhinitis Treatment

24th June 2021

Press release about Leadership Team expansion

Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment

20th January 2021

Press release about the $25 Million Series B Funding.

Neurent Medical raises €9.3m.

28th May 2018

A write up in the Irish Times.

Irish Medtech Awards finalists revealed.

2nd Nov 2018

Article on Ibec.ie

Frost & Sullivan recognises Neurent Medical.

13th Nov 2018

Article on Cision.

If you are a HealthCare Professional: Contact Customer Service to Place an Order

NEUROMARK is only available in the USA.

Call: 1-800-533-0695

Fax: 1-800-768-4183

E-mail : [email protected]

Questions?

Contact Us

No. 1 Oran Point, Main Street,
Oranmore, Galway, Ireland

US OFFICE
150 Grossman Dr, Suite 203
Braintree, MA 02184

General Enquiries

[email protected]

reversedlogoONLY

© Neurent Medical 2023

Terms & Conditions | Privacy Statement | Cookie Settings

The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your healthcare professional. We do not practice medicine or provide medical services or advice as a part of this website. You should always talk to your healthcare professional for diagnosis and treatment.

NEUROMARK device may be used in patients with recurring stuffy and/or runny nose. Your physician will need to determine if your condition is one that may benefit from NEUROMARK. Possible side effects include but are not limited to post-operative bleeding, pain or discomfort, allergic reaction to anesthesia or other medication administered during the procedure, and infection. Your condition may not respond to the treatment. To learn more about this procedure and potential risks, ask your physician.
INDICATIONS FOR USE: The NEUROMARK^® System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.

Please see Instructions for Use (IFU) for a complete listing of warnings, precautions, and adverse events.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
NEUROMARK is trademark of Neurent Medical. PAM026r01 October 2022 Copyright © 2022 Neurent Medical, Inc.